Experiences with

Benign prostatic hyperplasia

The nano-micellar curcumin improves International Prostate Symptoms Score (IPSS) in patients with benign prostatic hyperplasia: a randomized clinical trial https://pubmed.ncbi.nlm.nih.gov/37458774/

Prostate Health: Clinical research indicates that pumpkin seeds may help in relieving symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland enlarges.

My doc has prescribed this drug for benign prostatic hyperplasia. I need help with urinary frequency, urgency, and frequent night time urination. It is too early to tell if the drug is helping. It can three to six months to have the desired effect of reducing prostate swelling.

[/i] The full article (with links to the papers cited and a professional editortial comment) is linked below: [i]Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy - Study validates concerns about prostatic hyperplasia-related PSMA-PET false positives, by Kristin

Dad has been on BPH medicine since 2011 to control symptoms of prostate enlargement - It contains tamsulosin and dutaseride Recently he has also added xtandi - enzalutamide I read online on drug interaction sites that enzalutamide can reduce efficacy of tamsulosin. Did anyone who is on both

again, hopefully more results soon!! https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.16501

Before I got diagnosed with PCa , I was taking Tamsulosin plus Dutaseride for many years to control symptoms of BPH. My question is does taking them for many years show a false lower psa number than it actually would be ?

My PSA has risen over nearly 5.5 years since my prostatectomy from Undetectable to 0.3. I was referred to an RO who, after reviewing my test results and prior history, indicated that there were some "cells left behind" near the prostate bed, even though they tried to get at them unsuccessfully during

Hi everyone. Hoping to get some input from the collective experience and knowledge of the helpful people on this forum in making a decision on course of treatment. I apologize for length of post, but, with two issues (prostate and kidney) it took a bit to accurately explain. Newly diagnosed with Prostate

My PSA lows tend to be around 3.3, and it occurs to me that some might think it odd that I don't drive it lower. I think it is very common for men on ADT to draw too much comfort from a significant PSA reduction, if not a near-zero PSA. I have witnessed men misinterpret a dramatic drop in PSA as

Recent comprehensive paper on the use of liquid biopsies for diagnosis and treatment of PCa. Comprehensive summary tables are provided for both purposes. From the paper: [i]Introduction[/i] [i]The prostate-specific antigen (PSA) test is one of the most widely used screening tests for men at risk for

I have either benign prostatic hyperplasia or irritable bladder syndrome based on symptoms of nighttime urination and daytime frequency particularly when I consume caffeine, etc. Best wishes to all.

NOTE. This is the first time I have seen this this happening. I have found this new article, and…before I found this article, I have found a phase 3 clinical trial that is already applying these findings! Maybe a positive sign? Or an old article rebranded? Anyway look also for my other post about the

I am a bit slow, I am in Poland for work so I have to carve in the time to post. Mevrometostat (PF-06821497) is an experimental drug being investigated in a Phase III trial (NCT06551324) called MEVPRO-1. This trial is for men with metastatic castration-resistant prostate cancer (mCRPC) who have received

I am interested in your opinions as to who are the top 5 prostate oriented oncologists in the US. I would appreciate your opinions Thanks

The AMPLITUDE clinical trial (NCT04497844) is evaluating the effectiveness of Akeega, a combination of the PARP inhibitor niraparib and abiraterone acetate, along with prednisone, for treating metastatic castration-sensitive prostate cancer (mCSPC). This combination therapy is being compared to the

CAN-2409 is an immunotherapy drug currently in a Phase 3 clinical trial (PrTK03, NCT01436968) for individuals with intermediate-high risk localized prostate cancer. The trial, which is expected to conclude in December 2024, is evaluating the effectiveness of CAN-2409 in combination with radiation

This could literally save lives just by understanding the individual nature of each prostate cancer and metastasis. A study that used whole-body PET imaging with three different tracers assessed the prevalence of intrapatient intermetastatic heterogeneity (IIH) in patients with metastatic castration-resistant

Let's keep hoping... A Seattle-based biotech firm, has received a $2.4 million grant to develop CTT2274, a new drug for metastatic prostate cancer. CTT2274 is a small molecule drug conjugate that targets PSMA. This targeted approach delivers a toxic payload, MMAE, directly to tumor cells, potentially

Hi everyone. The quick stuff: I'm 73, diagnosed with prostate cancer about 3 weeks ago. From what my doc has told me, I fall somewhere in the low to moderate risk range. My gut feeling is not to fool around with this. At my age, I have no problem (well, mostly) with having my prostate removed. Can